Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
989
datasets available to search
ShareScore release 0.9.0
Dataset results
989 results for “myelodysplastic syndrome”
90Y-DOTA-anti-CD25 Basiliximab, Fludarabine, Melphalan, and Total Marrow and Lymphoid Irradiation for the Treatment of High-Risk Acute Leukemia or Myelodysplastic Syndrome
ClinicalTrials.gov study NCT05139004. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Dose-escalation Study of Oral Administration of S 055746 in Patients With Acute Myeloid Leukaemia or Myelodysplastic Syndrome
ClinicalTrials.gov study NCT02920541. IPD Sharing: YES. Countries: 2. Publications: 0.
A Single Arm Pilot Study of Azacitidine in Myelodysplastic Syndromes (MDS) / Acute Myeloid Leukaemia (AML), With Eltrombopag Support for Thrombocytopenia
ClinicalTrials.gov study NCT01488565. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Bortezomib and Low Dose Cytarabine in the Treatment of High-risk Myelodysplastic Syndromes
ClinicalTrials.gov study NCT00411905. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase I Study of Lintuzumab Combined With Lenalidomide in Patients With Myelodysplastic Syndromes (MDS)
ClinicalTrials.gov study NCT00502112. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Peripheral Blood Stem Cell Transplantation From Family Haploidentical Donors in Patients With Myelodysplastic Syndrome and Acute Leukemia Under Primary Prophylaxis With Posaconazole
ClinicalTrials.gov study NCT03434704. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Thalidomide in Treating Patients With Myelodysplastic Syndrome
ClinicalTrials.gov study NCT00015990. IPD Sharing: Not stated. Countries: 1. Publications: 0.
First-in-human (FIH) Trial of GEN3018 in Relapsed or Refractory (R/R) Acute Myeloid Leukemia (AML) or Higher-risk Myelodysplastic Syndrome (HR-MDS)
ClinicalTrials.gov study NCT07384715. IPD Sharing: NO. Countries: 0. Publications: 0.
Combination Chemotherapy and Antithymocyte Globulin in Reducing Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplantation For Myelodysplastic Syndrome or Myeloproliferative Diso
ClinicalTrials.gov study NCT00054340. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Asia Myelodysplastic Syndrome (MDS) Registry
ClinicalTrials.gov study NCT07355478. IPD Sharing: NO. Countries: 2. Publications: 0.
Belinostat and Bortezomib in Treating Patients With Relapsed or Refractory Acute Leukemia or Myelodysplastic Syndrome
ClinicalTrials.gov study NCT01075425. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase 1 Trial of ASTX030 in Patients With Myelodysplastic Syndrome
ClinicalTrials.gov study NCT04608110. IPD Sharing: YES. Countries: 1. Publications: 0.
Treatment of Elderly Patients With Acute Myeloid Leukemia (AML) and High Risk Myelodysplastic (MD) Syndrome With Laromustine and Infusional Cytarabine
ClinicalTrials.gov study NCT00655395. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT03970096. IPD Sharing: NO. Countries: 1. Publications: 0.
Study to Assess OPB-31121 in Advanced Leukemias or Myelodysplastic Syndromes
ClinicalTrials.gov study NCT01029509. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase 3 Clinical Study to Evaluate Lemzoparlimab for Injection in Combination With Azacitidine (AZA) Versus AZA Monotherapy in Treatment-naïve Patients With Higher-risk Myelodysplastic Syndrome (MDS
ClinicalTrials.gov study NCT05709093. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Impact of 2 Transfusion Strategies on Quality of Life of Multitransfused Patients With Low-risk Myelodysplastic Syndrome
ClinicalTrials.gov study NCT03643042. IPD Sharing: NO. Countries: 1. Publications: 0.
Efficacy of Immediate Allogeneic Hematopoietic Stem Cell Transplantation Versus Bridging Therapy Followed by Transplantation in Higher-Risk Myelodysplastic Syndrome Patients
ClinicalTrials.gov study NCT06918834. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of Oral Tetrahydrouridine-Decitabine in Relapsed or Refractory Myelodysplastic Syndromes (MDS)
ClinicalTrials.gov study NCT07006025. IPD Sharing: NO. Countries: 1. Publications: 0.
Evaluating the Efficacy of Deferasirox in Transfusion Dependent Chronic Anaemias (Myelodysplastic Syndrome, Beta-thalassaemia Patients) With Chronic Iron Overload
ClinicalTrials.gov study NCT00564941. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.